Evidence map›Paper›PMID 27835619›Full record

Observational studyAIDS (London, England)2017

HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control.

Selena Viganò, Jordi J Negrón, Samantha Tse, Fatema Z Chowdhury, Mathias Lichterfeld, Xu G Yu

Abstract readObservational Study
In one paragraph

Observational study in AIDS (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Selena ViganòaRagon Institute of MGH, MIT and Harvard bInfectious Disease Division, Massachusetts General Hospital cInfectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jordi J Negrón
Samantha Tse
Fatema Z Chowdhury
Mathias Lichterfeld
Xu G Yu

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
Immunoregulatory Function of Myelomonocytic Receptors in HIV-1 InfectionR01AI078799 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2008 to 2017
$4.1M
A systems biology approach to fingerprint HIV immune defense in Elite ControllersR01HL134539 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2016 to 2019
$3.3M
A Microengraving Technology for the Study of Latently HIV-infected Primary CellsR01AI089339 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2010 to 2013
$1.6M
A systems biology approach to fingerprint HIV immune defense in Elite ControllersR56HL126554 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2014 to 2014
$886k
A systems biology approach to fingerprint HIV immune defense in Elite ControllersR56AI098484 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2012 to 2012
$727k
NHLBI NIH HHS R01 HL134539NHLBI NIH HHS R56 HL126554NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI078799NIAID NIH HHS R01 AI089339NIAID NIH HHS R56 AI098484NIAID NIH HHS T32 AI007387
6 · The paper itself

Abstract

OBJECTIVE(S): To assess the frequency and function of HIV-1-specific HLA-G (histocompatibility antigen class I, G) CD8 T cells in HIV-1 controllers and progressors.

designWe performed an observational cross-sectional cohort analysis in untreated (n = 47) and treated (n = 17) HIV-1 patients with different rates of disease progression and n = 14 healthy individuals.

methodsWe evaluated the frequency, the proportion and the function of total and virus-specific HLA-G CD8 T cells by tetramer or intracellular cytokine staining, followed by flow cytometric analysis. Cytokine secretion of sorted CD8 T-cell subsets was evaluated by Luminex assays.

resultsThe proportion and the absolute frequency of HLA-G HIV-1-specific CD8 T cells were directly associated with CD4 T-cell counts and inversely correlated with viral loads, whereas total or HLA-G-negative HIV-1-specific CD8 T cells were not. In functional assays, HLA-G CD8 T cells from HIV-1-negative individuals had higher abilities to produce the antiviral (C-C chemokine receptor type 5) ligands MIP-1β (macrophage inflammatory protein-1ß), MIP-1α and Rantes.

conclusionHLA-G HIV-1-specific CD8 T cells may represent a previously unrecognized correlate of HIV-1 immune control.

Indexed as

CD8-Positive T-LymphocytesCohort StudiesCross-Sectional StudiesCytokinesFlow CytometryHIV InfectionsHLA-G AntigensHumansStaining and LabelingT-Lymphocyte SubsetsCytokinesHLA-G Antigens

Identifiers

PMID27835619
PMCPMC5177477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.